text:  Calu3-GemR_Veh_3 Calu3 human non-small lung cancer cells, gemcitabine resistant (Ligand) gemcitabine resistant Calu3 derivative generated from the parental Calu3 line by consecutive treatments with 50 nM gemcitabine over a period of 3 months